Suspected pulmonary embolism with severe renal impairment — MRCEM SBA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Arrange V/Q SPECT tomorrow; anticoagulate pending imaging.
His two-level PE Wells score is at least 4.5: 1.5 points each for tachycardia, surgery within 4 weeks and previous PE. PE is therefore ‘likely’, so the diagnostic pathway proceeds to imaging rather than D-dimer testing. His creatinine clearance of 23 mL/min meets NICE’s threshold for severe renal impairment, for which suitability for V/Q SPECT should be assessed as an alternative to CTPA. Because that scan cannot be performed immediately, he should receive interim therapeutic anticoagulation while awaiting it; his haemodynamic stability and absence of a bleeding contraindication support this plan. The anticoagulant choice must take his renal impairment into account. Arrange baseline blood tests and review their results, without delaying interim treatment. ([nice.org.uk](https://www.nice.org.uk/guidance/ng158/chapter/Recommendations)) A overlooks the renal-imaging exception. B selects the appropriate scan but leaves a likely PE untreated during the delay; it would be reasonable if imaging were immediate. D is the pathway for PE-unlikely patients, not this patient. E could establish DVT if leg symptoms were present, but he has none, and a negative leg scan would not resolve the suspected PE.
Reference: NICE NG158: Venous thromboembolic diseases — recommendations (Last updated 2 August 2023) — https://www.nice.org.uk/guidance/ng158/chapter/Recommendations NICE NG158: Venous thromboembolic diseases — recommendation 1.1.18 (Last updated 2 August 2023) — https://www.nice.org.uk/guidance/ng158/chapter/Recommendations NICE NG158: Anticoagulation treatment for suspected or confirmed DVT or PE (Guideline last updated 2 August 2023) — https://www.nice.org.uk/guidance/ng158/resources/venous-thromboembolic-diseases-diagnosis-management-and-thrombophilia-testing-pdf-66141847001797